Leading the next wave in psychedelics

Significant opportunities exist for investors as we advance psychedelic drug development beyond mental health. Become part of a movement to improve millions of lives.

Reach out to learn more

Watch our presentations.

See all resources

Watch our presentations.

See all resources

Eager to learn more about Tryp Therapeutics? Our presentations offer valuable insights for any type of investor.

Download the complete investor pack

Market opportunity

Tryp is pursuing chronic pain and other indications to address the significant needs of patients. Because of the relatively high prevalence of these diseases, the market opportunity for the successful development and commercialization of our treatments is enormous.

Diagnosed Prevalence in the U.S.

Peak Annual Worldwide Sales Potential for Tryp

Source: Tryp Therapeutics Projections

Eager to learn more about Tryp Therapeutics?

Contact us

Market data

See how our stock is trading.

Gain visibility into the trading activity of our shares with key performance indicators and historic data.

Analyst Coverage

Analyst Coverage

Tryp Therapeutics Inc. is followed by the analyst listed above. To the best of Tryp Therapeutics Inc.'s knowledge, the above list reflects all firms and analysts that publish research on Tryp Therapeutics Inc. and they have agreed to have their names included on the list above. Please note that any opinions, estimates or forecasts regarding Tryp Therapeutics Inc.’s performance made by such analysts are theirs alone and do not represent opinions, forecasts or predictions of Tryp Therapeutics Inc. or its management. Tryp Therapeutics Inc. does not by its reference imply its endorsement of or concurrence with such information, conclusions or recommendations.

Read our latest breakthroughs.

Learn more about our news and stay up to date on industry trends.

See all news

Join us for an event.

We regularly host and attend both virtual and in-person events.

See all events

Join us for an event.

We regularly host and attend both virtual and in-person events.

See all events

conference November 08 2021

Microdose: Wonderland Miami Conference

Wonderland: Miami programming will span across a variety of topics surrounding the psychedelics industry and beyond.


conference December 06 2021

H.C. Wainwright Annual Psychedelics Hybrid Conference

CEO Greg Mckee presents an overview of the Company pipeline and upcoming clinical milestones.

conference January 10 2022

JP Morgan Healthcare Conference

The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.

Investor resources

Get the latest information for investors.

Download our complete investor pack

See all resources

Investor presentation

Read the latest version of our investor deck, which includes information on our progress to date and our upcoming clinical activities.

Download now


Gain a deeper understanding of our pipeline and products.

Download now

Frequently asked questions

Get answers to common questions about Tryp, our clinical trials, commercialization and more.

Download now

Scientific literature

Learn more about the promise of psychedelics for chronic pain and other indications.

Read now